(BMRN) |
| 0 (0%) 01-13 19:36 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 63.89 |
| Resistance 1: | 58.93 |
| Pivot price: | 59.39 |
| Support 1: | 50.90 |
| Support 2: | 42.35 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 2.690 |
| Book Value | 31.530 |
| PEG Ratio | 0.00 |
| Gross Profit | 13.117 |
| Profit Margin (%) | 16.82 |
| Operating Margin (%) | -6.02 |
| Return on Assets (ttm) | 6.2 |
| Return on Equity (ttm) | 9.1 |
Company news
Tue, 13 Jan 2026
BMRN or TARS: Which Is the Better Value Stock Right Now? - Yahoo Finance
Tue, 13 Jan 2026
Is BioMarin Pharmaceutical (BMRN) a Great Value Stock Right Now? - Yahoo Finance
Tue, 13 Jan 2026
Does BioMarin Pharmaceutical (BMRN) Price Weakness Contrast With Its Cash Flow Valuation? - Yahoo Finance
Mon, 12 Jan 2026
Lobbying Update: $30,000 of BIOMARIN PHARMACEUTICAL INC. lobbying was just disclosed - Quiver Quantitative
Mon, 12 Jan 2026
BioMarin hires AI leader to help accelerate rare disease therapies - Stock Titan
Mon, 12 Jan 2026
BioMarin Appoints Arpit Davé Chief Digital and Information Officer - PR Newswire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
